NUS
Nu Skin Enterprises, Inc.NYSEConsumer DefensiveAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
2.23
PEG
0.01
P/B
0.45
P/S
0.24
EV/EBITDA
1.83
DCF Value
$17.83
FCF Yield
12.9%
Div Yield
3.2%
Margins & Returns
Gross Margin
69.4%
Operating Margin
4.4%
Net Margin
10.8%
ROE
20.4%
ROA
12.5%
ROIC
4.6%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $370.3M | $14.5M | $0.29 |
| FY 2025 | $1.49B | $160.2M | $3.18 |
| Q3 2025 | $364.2M | $17.1M | $0.34 |
| Q2 2025 | $386.1M | $21.1M | $0.43 |
Trading Activity
Insider Trades
View AllCompany Info
Sector
Consumer Defensive
Industry
—
Country
US
Exchange
NYSE
Beta
1.07
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.